BetterScholar BetterScholar
8
Role
Title
Level Year L/R
🐜 Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial
86 auth. Xinfeng Liu, Q. Dai, Ruidong Ye, W. Zi, Yuxiu Liu, Huaiming Wang, Wusheng Zhu, Minmin Ma, Q. Yin, Min Li, Xin-ying Fan, Wen Sun, Yunfei Han, Qiushi Lv, R. Liu, ... Dong Yang, Zhonghua Shi, D. Zheng, Xiaorong Deng, Y. Wan, Zhen Wang, Y. Geng, Xingyu Chen, Zhiming Zhou, Geng Liao, P. Jin, Yumin Liu, Xintong Liu, Meng Zhang, F. Zhou, Hongchao Shi, Yun-Feng Zhang, Fuqiang Guo, Congguo Yin, Guozhong Niu, Meikui Zhang, Xueli Cai, Qiyi Zhu, Zhonglun Chen, Yingchun Liang, Bing Li, Min Lin, Wei Wang, Haowen Xu, Xinmin Fu, Wen-hua Liu, X. Tian, Zi-li Gong, Haicun Shi, Chuanming Wang, P. Lv, Zhonghai Tao, Liang-fu Zhu, Shi-quan Yang, Wei Hu, Ping Jiang, D. Liebeskind, V. Pereira, T. Leung, B. Yan, S. Davis, Ge-lin Xu, R. Nogueira, Y. Xiong, Zongjie Shi, Wei-hong Zheng, Xianjun Huang, Yong Liu, Huagang Li, Kaifu Ke, Shu Yang, Hang Lin, W. Dan, Lin Chen, Liangqun Rong, Shui-ping Wang, Jin Fan, C. Xing, Haifeng Li, Weiming Yang, C. Wang, Yong Zhang, Xiaobo Li, V. Pereira, D. Liebeskind, R. Nogueira
8 2019
8
🐜
🐢 Effect of proppant distribution pattern on fracture conductivity and permeability in channel fracturing
7 auth. Xiaojin Zheng, Mian Chen, B. Hou, Zhihui Ye, Wei Wang, C. Yin, ... Xingyu Chen
5 2017
5
🐢
🐢 Tripeptide GGH as the Inhibitor of Copper-Amyloid-β-Mediated Redox Reaction and Toxicity.
7 auth. Xiaoyu Hu, Qian Zhang, Wei Wang, Zhi Yuan, Xushan Zhu, Bing-hai Chen, ... Xingyu Chen
5 2016
5
🐢
🐜 RECO Flow Restoration Device Versus Solitaire FR With the Intention for Thrombectomy Study (REDIRECT): a prospective randomized controlled trial.
12 auth. Jie Cao, Hang Lin, Min Lin, Kaifu Ke, Yun-Feng Zhang, Yong Zhang, ... Wei-hong Zheng, Xingyu Chen, Wei Wang, Meng Zhang, Jinggang Xuan, Ya Peng
3 2020
3
🐜